Does METHYLATROPINE Cause Mobility decreased? 13 Reports in FDA Database
Lower Your Cholesterol — The Natural Way
The Oxidized Cholesterol Strategy: a science-backed plan for heart health.
According to the FDA Adverse Event Reporting System (FAERS), 13 reports of Mobility decreased have been filed in association with METHYLATROPINE. This represents 86.7% of all adverse event reports for METHYLATROPINE.
13
Reports of Mobility decreased with METHYLATROPINE
86.7%
of all METHYLATROPINE reports
0
Deaths
12
Hospitalizations
How Dangerous Is Mobility decreased From METHYLATROPINE?
Of the 13 reports, 12 (92.3%) required hospitalization, and 9 (69.2%) were considered life-threatening.
Is Mobility decreased Listed in the Official Label?
This adverse event is not currently listed in the official FDA drug label for METHYLATROPINE. However, 13 reports have been filed with the FAERS database.
What Other Side Effects Does METHYLATROPINE Cause?
Balance disorder (13)
Blood calcium decreased (13)
Cognitive disorder (13)
Constipation (13)
Creatinine renal clearance decreased (13)
Depressed level of consciousness (13)
Fall (13)
Hypotension (13)
Orthostatic hypotension (13)
Pain (13)
What Other Drugs Cause Mobility decreased?
ADALIMUMAB (8,829)
ETANERCEPT (8,321)
METHOTREXATE (5,936)
ABATACEPT (4,519)
TOCILIZUMAB (4,403)
LEFLUNOMIDE (4,354)
HYDROXYCHLOROQUINE (4,105)
RITUXIMAB (4,067)
INFLIXIMAB (3,784)
TOFACITINIB (3,734)